Eli Lilly and Company Equity-NMS: LLY

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$703.21

Open :

$701.52

Today's high :

$705.8

Today's low :

$685.15

52W low :

$622.4129

52W high :

$965.149

EPS(TTM): :

15.22

Shares O/S :

896.46 M

Market cap :

632.4 B

What is the share price of Eli Lilly and Company today?

Eli Lilly and Company (LLY) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Eli Lilly and Company?

Yes, Indian Investors can invest in the Eli Lilly and Company (LLY) Share by opening an international trading account with Angel One.

How can I purchase Eli Lilly and Company shares in India?

Purchasing Eli Lilly and Company (LLY) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Eli Lilly and Company (LLY) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Eli Lilly and Company?

Yes, you can purchase fractional shares of Eli Lilly and Company (LLY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Eli Lilly and Company?

The market capitalization of Eli Lilly and Company on January 1, 1970, is $0.

What documents are required to invest in Eli Lilly and Company stocks?

In order to invest in Eli Lilly and Company (LLY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).